Skip to main content
Caplight Logo









Amara Therapeutics

Amara Therapeutics

Private
IrelandHealthcare & Life Scienceshttps://bladderboss.com/

Last Round

VC Round

Apr 23, 2025

Total Funding Raised

$3.3M

Company Overview

Amara Therapeutics is a digital therapeutics company that develops mobile health applications, including its flagship product BladderBoss, to provide behavioral interventions for pelvic and bladder health conditions.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, D2C Brands, Telemedicine, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

digital therapeuticsDTxurinary incontinencepelvic floor therapycognitive behavioral therapyCBTfemtechpelvic floor exercisesbladder healthsubscription appself-managed healthtelemedicinepatient engagementhealth-tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amara Therapeutics Comparables

Compare Amara Therapeutics with similar companies based on industry and business-model similarity.

Amara Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Renalis Health
88%
Axena Health
80%
Perifit
65%

Amara Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 23, 2025
SeedMay 8, 2023
GrantMay 8, 2023

Key People

Founding team and executive leadership

Emma Carr

Co-Founder and COO

Founding Team

Brendan Staunton

CEO Amara Therapeutics

Executive Team

Amara Therapeutics Investors

Notable investors and investment history

Amara Therapeutics investors
InvestorRounds
Western Development CommissionSeed
Enterprise IrelandVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 74% MoM, reaching 1.5K.

  • Jul 9, 2025

    Monthly visitors increased 141% MoM.

Amara Therapeutics Filings

Explore SEC and related filing metadata, where available.

Amara Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amara Therapeutics's valuation, stock price, and market status.

Is Amara Therapeutics a public or private company?

Amara Therapeutics is a private company.

What is the current stock price of Amara Therapeutics?

Amara Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Amara Therapeutics worth (valuation)?

Valuation information for Amara Therapeutics is not publicly available.

Can I buy Amara Therapeutics stock?

Amara Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amara Therapeutics's last funding round?

Amara Therapeutics's most recent funding round was VC Round on April 23, 2025.

Who are the main investors in Amara Therapeutics?

Key investors in Amara Therapeutics include Western Development Commission, Enterprise Ireland.

Will Amara Therapeutics IPO soon?

No public IPO plans have been announced for Amara Therapeutics.

How can I track Amara Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amara Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIreland
Employee Range6
Year Founded2021
Last FundingApr 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?